- Joined
- Jun 8, 2019
- Messages
- 1,976
- Reaction score
- 3,570
Am I allowed to post the whole article here (for those facing a paywall? Ive posted a portion of it):
In Today's NYT:
GLOBAL HEALTH
To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions
"About 80 million people with diabetes around the world need the hormone, and half of them can’t afford it. Creating competition could help, the agency said.
With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health Organization said on Wednesday that it would begin testing and approving generic versions of the drug.
Agency officials said they hoped to drive down insulin prices by encouraging makers of generic drugs to enter the market, increasing competition. At the moment, the world’s insulin market is dominated by three companies — Eli Lilly, Novo Nordisk and Sanofi — and they have steadily pushed up prices for two decades.
“Four hundred million people are living with diabetes, the amount of insulin available is too low and the price is too high, so we really need to do something,” Emer Cooke, the W.H.O.’s head of regulation of medicines and health technologies, said as she announced the plan.
The approval process, which the W.H.O. calls “prequalification,” will permit United Nations agencies and medical charities like Doctors Without Borders to buy approved generic versions of insulin....."
To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions (Published 2019)
About 80 million people with diabetes around the world need the hormone, and half of them can’t afford it. Creating competition could help, the agency said.
www.nytimes.com
In Today's NYT:
GLOBAL HEALTH
To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions
"About 80 million people with diabetes around the world need the hormone, and half of them can’t afford it. Creating competition could help, the agency said.
With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health Organization said on Wednesday that it would begin testing and approving generic versions of the drug.
Agency officials said they hoped to drive down insulin prices by encouraging makers of generic drugs to enter the market, increasing competition. At the moment, the world’s insulin market is dominated by three companies — Eli Lilly, Novo Nordisk and Sanofi — and they have steadily pushed up prices for two decades.
“Four hundred million people are living with diabetes, the amount of insulin available is too low and the price is too high, so we really need to do something,” Emer Cooke, the W.H.O.’s head of regulation of medicines and health technologies, said as she announced the plan.
The approval process, which the W.H.O. calls “prequalification,” will permit United Nations agencies and medical charities like Doctors Without Borders to buy approved generic versions of insulin....."